Selected research
Market Analysis & Forecast
Global Corporate Telehealth Market Analysis and Forecast 2026-2032
Market perspective
The global Corporate Telehealth market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Corporate Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Corporate Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Corporate Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Corporate Telehealth is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Corporate Telehealth include HALODOC, Alodokter, ProSehat, Good Doctor, aido health, PT Medika Komunika Teknologi, Vascular Indonesia, Get Healthy Indonesia and Intel Corporation, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Corporate Telehealth, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Corporate Telehealth, also provides the revenue of main regions and countries. Of the upcoming market potential for Corporate Telehealth, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Corporate Telehealth revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Corporate Telehealth market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Corporate Telehealth revenue, projected growth trends, production technology, application and end-user industry.
Corporate Telehealth Segment by Company
HALODOC
Alodokter
ProSehat
Good Doctor
aido health
PT Medika Komunika Teknologi
Vascular Indonesia
Get Healthy Indonesia
Intel Corporation
Cisco Systems
Inc Healthy Link
Trustmedis Indonesia
Teladoc Health
Doctor On Demand
Amwell
MDLIVE
Cigna Corporation
Aetna
UnitedHealth Group
Corporate Telehealth Segment by Type
Cloud-based
On-Premise
Corporate Telehealth Segment by Application
Healthcare Providers
Healthcare Payers
Patients
Corporate Telehealth Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corporate Telehealth market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Corporate Telehealth and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corporate Telehealth.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Corporate Telehealth in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Corporate Telehealth company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Corporate Telehealth revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-Premise
Applications
- Healthcare Providers
- Healthcare Payers
- Patients
Companies covered
- HALODOC
- Alodokter
- ProSehat
- Good Doctor
- aido health
- PT Medika Komunika Teknologi
- Vascular Indonesia
- Get Healthy Indonesia
- Intel Corporation
- Cisco Systems
- Inc Healthy Link
- Trustmedis Indonesia
- Teladoc Health
- Doctor On Demand
- Amwell
- MDLIVE
- Cigna Corporation
- Aetna
- UnitedHealth Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Corporate Telehealth Market by Type
- 1.2.1 Global Corporate Telehealth Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Cloud-based
- 1.2.3 On-Premise
- 1.3 Corporate Telehealth Market by Application
- 1.3.1 Global Corporate Telehealth Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Healthcare Providers
- 1.3.3 Healthcare Payers
- 1.3.4 Patients
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Corporate Telehealth Market Dynamics
- 2.1 Corporate Telehealth Industry Trends
- 2.2 Corporate Telehealth Industry Drivers
- 2.3 Corporate Telehealth Industry Opportunities and Challenges
- 2.4 Corporate Telehealth Industry Restraints
3 Global Growth Perspective
- 3.1 Global Corporate Telehealth Market Perspective (2021-2032)
- 3.2 Global Corporate Telehealth Growth Trends by Region
- 3.2.1 Global Corporate Telehealth Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Corporate Telehealth Market Size by Region (2021-2026)
- 3.2.3 Global Corporate Telehealth Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Corporate Telehealth Revenue by Players
- 4.1.1 Global Corporate Telehealth Revenue by Players (2021-2026)
- 4.1.2 Global Corporate Telehealth Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Corporate Telehealth Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Corporate Telehealth Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Corporate Telehealth Key Players Headquarters & Area Served
- 4.4 Global Corporate Telehealth Players, Product Type & Application
- 4.5 Global Corporate Telehealth Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Corporate Telehealth Market CR5 and HHI
- 4.6.3 2025 Corporate Telehealth Tier 1, Tier 2, and Tier 3
5 Corporate Telehealth Market Size by Type
- 5.1 Global Corporate Telehealth Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Corporate Telehealth Revenue by Type (2021-2032)
- 5.3 Global Corporate Telehealth Revenue Market Share by Type (2021-2032)
6 Corporate Telehealth Market Size by Application
- 6.1 Global Corporate Telehealth Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Corporate Telehealth Revenue by Application (2021-2032)
- 6.3 Global Corporate Telehealth Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 HALODOC
- 7.1.1 HALODOC Company Information
- 7.1.2 HALODOC Business Overview
- 7.1.3 HALODOC Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.1.4 HALODOC Corporate Telehealth Product Portfolio
- 7.1.5 HALODOC Recent Developments
- 7.2 Alodokter
- 7.2.1 Alodokter Company Information
- 7.2.2 Alodokter Business Overview
- 7.2.3 Alodokter Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.2.4 Alodokter Corporate Telehealth Product Portfolio
- 7.2.5 Alodokter Recent Developments
- 7.3 ProSehat
- 7.3.1 ProSehat Company Information
- 7.3.2 ProSehat Business Overview
- 7.3.3 ProSehat Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.3.4 ProSehat Corporate Telehealth Product Portfolio
- 7.3.5 ProSehat Recent Developments
- 7.4 Good Doctor
- 7.4.1 Good Doctor Company Information
- 7.4.2 Good Doctor Business Overview
- 7.4.3 Good Doctor Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.4.4 Good Doctor Corporate Telehealth Product Portfolio
- 7.4.5 Good Doctor Recent Developments
- 7.5 aido health
- 7.5.1 aido health Company Information
- 7.5.2 aido health Business Overview
- 7.5.3 aido health Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.5.4 aido health Corporate Telehealth Product Portfolio
- 7.5.5 aido health Recent Developments
- 7.6 PT Medika Komunika Teknologi
- 7.6.1 PT Medika Komunika Teknologi Company Information
- 7.6.2 PT Medika Komunika Teknologi Business Overview
- 7.6.3 PT Medika Komunika Teknologi Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.6.4 PT Medika Komunika Teknologi Corporate Telehealth Product Portfolio
- 7.6.5 PT Medika Komunika Teknologi Recent Developments
- 7.7 Vascular Indonesia
- 7.7.1 Vascular Indonesia Company Information
- 7.7.2 Vascular Indonesia Business Overview
- 7.7.3 Vascular Indonesia Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.7.4 Vascular Indonesia Corporate Telehealth Product Portfolio
- 7.7.5 Vascular Indonesia Recent Developments
- 7.8 Get Healthy Indonesia
- 7.8.1 Get Healthy Indonesia Company Information
- 7.8.2 Get Healthy Indonesia Business Overview
- 7.8.3 Get Healthy Indonesia Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.8.4 Get Healthy Indonesia Corporate Telehealth Product Portfolio
- 7.8.5 Get Healthy Indonesia Recent Developments
- 7.9 Intel Corporation
- 7.9.1 Intel Corporation Company Information
- 7.9.2 Intel Corporation Business Overview
- 7.9.3 Intel Corporation Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.9.4 Intel Corporation Corporate Telehealth Product Portfolio
- 7.9.5 Intel Corporation Recent Developments
- 7.10 Cisco Systems
- 7.10.1 Cisco Systems Company Information
- 7.10.2 Cisco Systems Business Overview
- 7.10.3 Cisco Systems Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.10.4 Cisco Systems Corporate Telehealth Product Portfolio
- 7.10.5 Cisco Systems Recent Developments
- 7.11 Inc Healthy Link
- 7.11.1 Inc Healthy Link Company Information
- 7.11.2 Inc Healthy Link Business Overview
- 7.11.3 Inc Healthy Link Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.11.4 Inc Healthy Link Corporate Telehealth Product Portfolio
- 7.11.5 Inc Healthy Link Recent Developments
- 7.12 Trustmedis Indonesia
- 7.12.1 Trustmedis Indonesia Company Information
- 7.12.2 Trustmedis Indonesia Business Overview
- 7.12.3 Trustmedis Indonesia Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.12.4 Trustmedis Indonesia Corporate Telehealth Product Portfolio
- 7.12.5 Trustmedis Indonesia Recent Developments
- 7.13 Teladoc Health
- 7.13.1 Teladoc Health Company Information
- 7.13.2 Teladoc Health Business Overview
- 7.13.3 Teladoc Health Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.13.4 Teladoc Health Corporate Telehealth Product Portfolio
- 7.13.5 Teladoc Health Recent Developments
- 7.14 Doctor On Demand
- 7.14.1 Doctor On Demand Company Information
- 7.14.2 Doctor On Demand Business Overview
- 7.14.3 Doctor On Demand Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.14.4 Doctor On Demand Corporate Telehealth Product Portfolio
- 7.14.5 Doctor On Demand Recent Developments
- 7.15 Amwell
- 7.15.1 Amwell Company Information
- 7.15.2 Amwell Business Overview
- 7.15.3 Amwell Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.15.4 Amwell Corporate Telehealth Product Portfolio
- 7.15.5 Amwell Recent Developments
- 7.16 MDLIVE
- 7.16.1 MDLIVE Company Information
- 7.16.2 MDLIVE Business Overview
- 7.16.3 MDLIVE Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.16.4 MDLIVE Corporate Telehealth Product Portfolio
- 7.16.5 MDLIVE Recent Developments
- 7.17 Cigna Corporation
- 7.17.1 Cigna Corporation Company Information
- 7.17.2 Cigna Corporation Business Overview
- 7.17.3 Cigna Corporation Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.17.4 Cigna Corporation Corporate Telehealth Product Portfolio
- 7.17.5 Cigna Corporation Recent Developments
- 7.18 Aetna
- 7.18.1 Aetna Company Information
- 7.18.2 Aetna Business Overview
- 7.18.3 Aetna Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.18.4 Aetna Corporate Telehealth Product Portfolio
- 7.18.5 Aetna Recent Developments
- 7.19 UnitedHealth Group
- 7.19.1 UnitedHealth Group Company Information
- 7.19.2 UnitedHealth Group Business Overview
- 7.19.3 UnitedHealth Group Corporate Telehealth Revenue and Gross Margin (2021-2026)
- 7.19.4 UnitedHealth Group Corporate Telehealth Product Portfolio
- 7.19.5 UnitedHealth Group Recent Developments
8 North America
- 8.1 North America Corporate Telehealth Revenue (2021-2032)
- 8.2 North America Corporate Telehealth Revenue by Type (2021-2032)
- 8.2.1 North America Corporate Telehealth Revenue by Type (2021-2026)
- 8.2.2 North America Corporate Telehealth Revenue by Type (2027-2032)
- 8.3 North America Corporate Telehealth Revenue Share by Type (2021-2032)
- 8.4 North America Corporate Telehealth Revenue by Application (2021-2032)
- 8.4.1 North America Corporate Telehealth Revenue by Application (2021-2026)
- 8.4.2 North America Corporate Telehealth Revenue by Application (2027-2032)
- 8.5 North America Corporate Telehealth Revenue Share by Application (2021-2032)
- 8.6 North America Corporate Telehealth Revenue by Country
- 8.6.1 North America Corporate Telehealth Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Corporate Telehealth Revenue by Country (2021-2026)
- 8.6.3 North America Corporate Telehealth Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Corporate Telehealth Revenue (2021-2032)
- 9.2 Europe Corporate Telehealth Revenue by Type (2021-2032)
- 9.2.1 Europe Corporate Telehealth Revenue by Type (2021-2026)
- 9.2.2 Europe Corporate Telehealth Revenue by Type (2027-2032)
- 9.3 Europe Corporate Telehealth Revenue Share by Type (2021-2032)
- 9.4 Europe Corporate Telehealth Revenue by Application (2021-2032)
- 9.4.1 Europe Corporate Telehealth Revenue by Application (2021-2026)
- 9.4.2 Europe Corporate Telehealth Revenue by Application (2027-2032)
- 9.5 Europe Corporate Telehealth Revenue Share by Application (2021-2032)
- 9.6 Europe Corporate Telehealth Revenue by Country
- 9.6.1 Europe Corporate Telehealth Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Corporate Telehealth Revenue by Country (2021-2026)
- 9.6.3 Europe Corporate Telehealth Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Corporate Telehealth Revenue (2021-2032)
- 10.2 China Corporate Telehealth Revenue by Type (2021-2032)
- 10.2.1 China Corporate Telehealth Revenue by Type (2021-2026)
- 10.2.2 China Corporate Telehealth Revenue by Type (2027-2032)
- 10.3 China Corporate Telehealth Revenue Share by Type (2021-2032)
- 10.4 China Corporate Telehealth Revenue by Application (2021-2032)
- 10.4.1 China Corporate Telehealth Revenue by Application (2021-2026)
- 10.4.2 China Corporate Telehealth Revenue by Application (2027-2032)
- 10.5 China Corporate Telehealth Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Corporate Telehealth Revenue (2021-2032)
- 11.2 Asia Corporate Telehealth Revenue by Type (2021-2032)
- 11.2.1 Asia Corporate Telehealth Revenue by Type (2021-2026)
- 11.2.2 Asia Corporate Telehealth Revenue by Type (2027-2032)
- 11.3 Asia Corporate Telehealth Revenue Share by Type (2021-2032)
- 11.4 Asia Corporate Telehealth Revenue by Application (2021-2032)
- 11.4.1 Asia Corporate Telehealth Revenue by Application (2021-2026)
- 11.4.2 Asia Corporate Telehealth Revenue by Application (2027-2032)
- 11.5 Asia Corporate Telehealth Revenue Share by Application (2021-2032)
- 11.6 Asia Corporate Telehealth Revenue by Country
- 11.6.1 Asia Corporate Telehealth Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Corporate Telehealth Revenue by Country (2021-2026)
- 11.6.3 Asia Corporate Telehealth Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Corporate Telehealth Revenue (2021-2032)
- 12.2 SAMEA Corporate Telehealth Revenue by Type (2021-2032)
- 12.2.1 SAMEA Corporate Telehealth Revenue by Type (2021-2026)
- 12.2.2 SAMEA Corporate Telehealth Revenue by Type (2027-2032)
- 12.3 SAMEA Corporate Telehealth Revenue Share by Type (2021-2032)
- 12.4 SAMEA Corporate Telehealth Revenue by Application (2021-2032)
- 12.4.1 SAMEA Corporate Telehealth Revenue by Application (2021-2026)
- 12.4.2 SAMEA Corporate Telehealth Revenue by Application (2027-2032)
- 12.5 SAMEA Corporate Telehealth Revenue Share by Application (2021-2032)
- 12.6 SAMEA Corporate Telehealth Revenue by Country
- 12.6.1 SAMEA Corporate Telehealth Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Corporate Telehealth Revenue by Country (2021-2026)
- 12.6.3 SAMEA Corporate Telehealth Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst